Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders
Article in Frontiers in Endocrinology (June 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Environmental Triggering of Type 1 Diabetes Autoimmunity
Article in Frontiers in Endocrinology (July 2022)
Roles and Therapeutic Implications of Endoplasmic Reticulum Stress and Oxidative Stress in Cardiovascular Diseases
Article in Antioxidants (July 2021)